Literature DB >> 19281160

Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles.

Rong Tong1, Jianjun Cheng.   

Abstract

We report here a unique method for formulating doxorubicin-polylactide (Doxo-PLA) conjugate nanoparticles, known as nanoconjugates (NCs), through Doxo/(BDI)ZnN(TMS)(2)-mediated [(BDI) = 2-((2,6-diisopropylphenyl)amido)-4-((2,6-diisopropylphenyl)-imino)-2-pentene], chemo- and regioselective polymerizations of lactide (LA) followed by nanoprecipitation. When Doxo/(BDI)ZnN(TMS)(2) was mixed with 1-pyrenemethanol (Pyr-OH) and 1-pyrenemethylamine (Pyr-NH(2)) and the mixture was utilized for the polymerization of LA, remarkable chemoselectivity was observed. Pyr-OH was completely consumed and covalently linked to the terminus of the PLA, whereas the Pyr-NH(2) remained intact in the polymerization solution. When Doxo was used as the initiator to polymerize LA in the presence of (BDI)ZnN(TMS)(2), the polymerization was complete within hours, with nearly 100% Doxo-loading efficiency and 100% LA conversion. Doxo loading as high as 27% could be achieved at a LA/Doxo ratio of 10. Both the steric bulk of the chelating ligand and the metal catalyst had dramatic effects on the regioselectivity during the initiation step. When Doxo/(BDI)ZnN(TMS)(2) was mixed with succinic anhydride (SA) to mimic the initiation of Doxo/(BDI)ZnN(TMS)(2)-mediated LA polymerization, Doxo-14-succinic ester (Doxo-SE) was the predominate product. When the steric bulk of BDI was reduced or when the BDI ligand was removed, significant amounts of Doxo-4',14-bis-succinic ester (Doxo-2SE) and Doxo-4',9,14-trisuccinic ester (Doxo-3SE) were formed. The use of (BDI)MgN(TMS)(2) in such a reaction also resulted in reduced regioselectivity and formation of both Doxo-SE and Doxo-2SE. Doxo/(BDI)ZnN(TMS)(2)-mediated LA polymerizations yielded Doxo-PLA conjugates with well-controlled molecular weights and polydispersities (as low as 1.02). The nanoprecipitation of Doxo-PLA formed NCs less than 150 nm in size with narrow particle size distributions. The sustained release of Doxo from Doxo-PLA NCs was achieved without a burst release. This method may have widespread utility for controlled conjugation of hydroxyl-containing agents to polyesters and formation of corresponding nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281160     DOI: 10.1021/ja8084675

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  37 in total

1.  Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery.

Authors:  Jiong Zou; Fuwu Zhang; Shiyi Zhang; Stephanie F Pollack; Mahmoud Elsabahy; Jingwei Fan; Karen L Wooley
Journal:  Adv Healthc Mater       Date:  2013-08-30       Impact factor: 9.933

2.  Anticancer Camptothecin-N-Poly(lactic acid) Nanoconjugates with Facile Hydrolysable Linker.

Authors:  Qian Yin; Rong Tong; Lichen Yin; Timothy M Fan; Jianjun Cheng
Journal:  Polym Chem       Date:  2014       Impact factor: 5.582

3.  Chain-shattering polymeric therapeutics with on-demand drug-release capability.

Authors:  Yanfeng Zhang; Qian Yin; Lichen Yin; Liang Ma; Li Tang; Jianjun Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

4.  Lymphatic biodistribution of polylactide nanoparticles.

Authors:  Eric J Chaney; Li Tang; Rong Tong; Jianjun Cheng; Stephen A Boppart
Journal:  Mol Imaging       Date:  2010-06       Impact factor: 4.488

5.  Facile functionalization of polyesters through thiol-yne chemistry for the design of degradable, cell-penetrating and gene delivery dual-functional agents.

Authors:  Zhonghai Zhang; Lichen Yin; Yunxiang Xu; Rong Tong; Yanbing Lu; Jie Ren; Jianjun Cheng
Journal:  Biomacromolecules       Date:  2012-10-26       Impact factor: 6.988

6.  Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates.

Authors:  Rong Tong; Jianjun Cheng
Journal:  Bioconjug Chem       Date:  2010-01       Impact factor: 4.774

7.  Development of high drug loaded and customizing novel nanoparticles for modulated and controlled release of Paclitaxel.

Authors:  Primiano Pio Di Mauro; Salvador Borrós
Journal:  Pharm Res       Date:  2014-06-18       Impact factor: 4.200

8.  Redox-Responsive, Core Cross-Linked Polyester Micelles.

Authors:  Zhonghai Zhang; Lichen Yin; Chunlai Tu; Ziyuan Song; Yanfeng Zhang; Yunxiang Xu; Rong Tong; Qin Zhou; Jie Ren; Jianjun Cheng
Journal:  ACS Macro Lett       Date:  2012-12-24       Impact factor: 6.903

9.  Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugates.

Authors:  Qian Yin; Rong Tong; Yunxiang Xu; Kwanghyun Baek; Lawrence W Dobrucki; Timothy M Fan; Jianjun Cheng
Journal:  Biomacromolecules       Date:  2013-02-27       Impact factor: 6.988

10.  Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis.

Authors:  Qian Yin; Li Tang; Kaimin Cai; Rong Tong; Rachel Sternberg; Xujuan Yang; Lawrence W Dobrucki; Luke B Borst; Debra Kamstock; Ziyuan Song; William G Helferich; Jianjun Cheng; Timothy M Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.